Modular Medical Inc. (MODD)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
-Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements -Effort will be led be Nudge BG founder and noted AID expert, Lane Desborough SAN DIEGO, CA / ACCESSWIRE / December 19, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, announced a licensing and partnership agreement with Nudge BG. "We are very excited to partner with Modular Medical to bring the next generation of automated insulin delivery ("AID") to the marketplace," said Lane Desborough, CEO of Nudge BG.
Modular Medical Announces Pricing of $8.2 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has priced an underwritten public offering (the "offering") of 5,450,573 shares of its common stock. The offering was led by existing institutional investors, including Manchester Explorer, L.P.
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has commenced an underwritten public offering (the "offering") of shares of its common stock (or pre-funded warrants to purchase shares of its common stock in lieu thereof). Modular Medical also has granted the underwriter a 30-day option to purchase up to an additional 15% of the aggregate number of shares of its common stock (or pre-funded warrants) sold in the offering.
Modular Medical Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MB Michael Byun SageView Advisory Group LLC | 375.8 | $25,623.07 | $1,781.31 | -$23,841.76 | -93.05% |
Modular Medical Inc. (MODD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Modular Medical Inc. ever had a stock split?
Modular Medical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | James E. Besser CEO | NASDAQ (CM) Exchange | 60785L306 CUSIP |
| US Country | 39 Employees | - Last Dividend | 31 Mar 2026 Last Split | 25 Jan 2007 IPO Date |
Overview
Modular Medical, Inc. is a development stage medical device company engaged in the design, development, and eventual commercialization of innovative insulin pumps. Founded in 1998, the company has been focusing its efforts on creating solutions that enhance the quality of life for individuals with diabetes. With its headquarters located in San Diego, California, Modular Medical is poised to contribute significantly to the medical device industry, especially in the field of diabetes management. Their dedication to developing advanced medical technologies showcases their commitment to improving patient care and outcomes.
Products and Services
- MODD1
The MODD1 is a two-part patch pump specifically designed for diabetes patients. As a standout product in Modular Medical’s portfolio, the MODD1 aims to revolutionize insulin delivery by providing a more convenient, discreet, and efficient method of managing blood glucose levels. This innovative approach to insulin therapy underscores the company's focus on leveraging technology to enhance the well-being of individuals with diabetes.
